Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries-Reference-Cited by-同舟云学术

Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries

Published:2023-12-12 Issue:24 Volume:24 Page:17407
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Palladini Giuseppina¹²^ORCID,Di Pasqua Laura Giuseppina¹^ORCID,Croce Anna Cleta³⁴^ORCID,Ferrigno Andrea¹^ORCID,Vairetti Mariapia¹^ORCID

Affiliation:

1. Department of Internal Medicine and Therapeutics, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy

2. Internal Medicine Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100 Pavia, Italy

3. Institute of Molecular Genetics, Italian National Research Council (CNR), Via Abbiategrasso 207, 27100 Pavia, Italy

4. Department of Biology & Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy

Abstract

The reversion-inducing cysteine-rich protein with Kazal motifs (RECK), a membrane-anchored glycoprotein, negatively regulates various membrane proteins involved in the tissue governing extracellular matrix (ECM) remodeling such as metalloproteases (MMPs) and the sheddases ADAM10 and ADAM17. The significance of the present review is to summarize the current understanding of the pathophysiological role of RECK, a newly discovered signaling pathway associated with different liver injuries. Specifically, this review analyzes published data on the downregulation of RECK expression in hepatic ischemia/reperfusion (I/R) injury, liver-related cancers, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), as well as in the progression of nonalcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH). In addition, this review discusses the regulation of RECK by inducers, such as FXR agonists. The RECK protein has also been suggested as a potential diagnostic and prognostic marker for liver injury or as a biomarker with predictive value for drug treatment efficacy.

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/24/17407/pdf

Reference85 articles.

1. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis;Oh;Cell,2001

2. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene;Takahashi;Oncogene,1996

3. RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase-catalyzed cleavage of fibronectin;Omura;J. Biol. Chem.,2009

4. Muñoz-Sáez, E., Moracho, N., Learte, A.I.R., Collignon, A., Arroyo, A.G., Noel, A., Sounni, N.E., and Sánchez-Camacho, C. (2023). Molecular Mechanisms Driven by MT4-MMP in Cancer Progression. Int. J. Mol. Sci., 24.

5. Xu, D., Dai, R., Chi, H., Ge, W., and Rong, J. (2021). Long Non-Coding RNA MEG8 Suppresses Hypoxia-Induced Excessive Proliferation, Migration and Inflammation of Vascular Smooth Muscle Cells by Regulation of the miR-195-5p/RECK Axis. Front. Mol. Biosci., 8.